The family of a deceased Virginia man has filed a testosterone lawsuit (http://www.drugbot.com/testosterone/lawsuit/) that accuses the manufacturer of the AndroDerm ...

October 21, 2011 — The US Food and Drug Administration (FDA) has approved 2 lower-dose formulations of Watson Pharmaceutical's Androderm (testosterone transdermal system), the company announced today.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a new formulation of a testosterone therapy made by Watson Pharmaceuticals, the drug maker said Friday. Watson announced the approval ...

The FDA has approved two lower-dose formulations for Androderm, a once-daily transdermal patch for men with low testosterone. Androderm is manufactured by Watson Pharmaceuticals, Inc. in Corona, Calif ...

The Food and Drug Administration has approved a hormone skin patch for men who have very low levels of testosterone, a disorder known as hypogonadism. Known as Androderm, the patch slowly releases ...

The FDA has approved Androderm (testosterone transdermal system; Watson) in 2mg and 4mg formulations. The smaller-sized and lower-dose patch reflects a 20% reduction in the active ingredient from the ...